U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Fallopian Tube Transitional Cell Carcinoma

MedGen UID:
1728175
•Concept ID:
C5418774
•
Neoplastic Process

Definition

The reemergence of fallopian tube transitional cell carcinoma after a period of remission. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent Fallopian Tube Transitional Cell Carcinoma

Recent clinical studies

Etiology

Phase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancer.
Chelariu-Raicu A, Levenback CF, Slomovitz BM, Wolf J, Bodurka DC, Kavanagh JJ, Morrison C, Gershenson DM, Coleman RL
Int J Gynecol Cancer 2020 Nov;30(11):1768-1774. Epub 2020 Oct 9 doi: 10.1136/ijgc-2020-001863. PMID: 33037105
Phase 1 and 2 study of carboplatin and pralatrexate in patients with recurrent, platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer.
Del Carmen MG, Supko JG, Horick NK, Rauh-Hain JA, Clark RM, Campos SM, Krasner CN, Atkinson T, Birrer MJ
Cancer 2016 Nov 15;122(21):3297-3306. Epub 2016 Jul 15 doi: 10.1002/cncr.30196. PMID: 27421044
Plasmacytoid carcinoma of the bladder: a urothelial carcinoma variant with a predilection for intraperitoneal spread.
Ricardo-Gonzalez RR, Nguyen M, Gokden N, Sangoi AR, Presti JC Jr, McKenney JK
J Urol 2012 Mar;187(3):852-5. Epub 2012 Jan 15 doi: 10.1016/j.juro.2011.10.145. PMID: 22245324
Uterus-, fallopian tube-, ovary-, and vagina-sparing cystectomy followed by U-shaped ileal neobladder construction for female bladder cancer patients: oncological and functional outcomes.
Koie T, Hatakeyama S, Yoneyama T, Hashimoto Y, Kamimura N, Ohyama C
Urology 2010 Jun;75(6):1499-503. Epub 2009 Dec 6 doi: 10.1016/j.urology.2009.08.083. PMID: 19969331
Transitional cell carcinoma of the endometrium and endometrial carcinoma with transitional cell differentiation.
Lininger RA, Ashfaq R, Albores-Saavedra J, Tavassoli FA
Cancer 1997 May 15;79(10):1933-43. PMID: 9149020

Diagnosis

Primary transitional cell carcinoma of the fallopian tube: A case report and literature review.
Lee DH, Cho DH, Kim KM, Yim CY, Lee NR
Medicine (Baltimore) 2020 May 29;99(22):e20499. doi: 10.1097/MD.0000000000020499. PMID: 32481467
Phase 1 and 2 study of carboplatin and pralatrexate in patients with recurrent, platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer.
Del Carmen MG, Supko JG, Horick NK, Rauh-Hain JA, Clark RM, Campos SM, Krasner CN, Atkinson T, Birrer MJ
Cancer 2016 Nov 15;122(21):3297-3306. Epub 2016 Jul 15 doi: 10.1002/cncr.30196. PMID: 27421044
Plasmacytoid carcinoma of the bladder: a urothelial carcinoma variant with a predilection for intraperitoneal spread.
Ricardo-Gonzalez RR, Nguyen M, Gokden N, Sangoi AR, Presti JC Jr, McKenney JK
J Urol 2012 Mar;187(3):852-5. Epub 2012 Jan 15 doi: 10.1016/j.juro.2011.10.145. PMID: 22245324
A case of primary transitional cell carcinoma of the fallopian tube.
Kim JW, Cho EM, Kim YT, Han JH
J Obstet Gynaecol Res 1999 Oct;25(5):321-6. doi: 10.1111/j.1447-0756.1999.tb01170.x. PMID: 10533326
Transitional cell carcinoma of the endometrium and endometrial carcinoma with transitional cell differentiation.
Lininger RA, Ashfaq R, Albores-Saavedra J, Tavassoli FA
Cancer 1997 May 15;79(10):1933-43. PMID: 9149020

Therapy

Phase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancer.
Chelariu-Raicu A, Levenback CF, Slomovitz BM, Wolf J, Bodurka DC, Kavanagh JJ, Morrison C, Gershenson DM, Coleman RL
Int J Gynecol Cancer 2020 Nov;30(11):1768-1774. Epub 2020 Oct 9 doi: 10.1136/ijgc-2020-001863. PMID: 33037105
Primary transitional cell carcinoma of the fallopian tube: A case report and literature review.
Lee DH, Cho DH, Kim KM, Yim CY, Lee NR
Medicine (Baltimore) 2020 May 29;99(22):e20499. doi: 10.1097/MD.0000000000020499. PMID: 32481467
Phase 1 and 2 study of carboplatin and pralatrexate in patients with recurrent, platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer.
Del Carmen MG, Supko JG, Horick NK, Rauh-Hain JA, Clark RM, Campos SM, Krasner CN, Atkinson T, Birrer MJ
Cancer 2016 Nov 15;122(21):3297-3306. Epub 2016 Jul 15 doi: 10.1002/cncr.30196. PMID: 27421044
Uterus-, fallopian tube-, ovary-, and vagina-sparing cystectomy followed by U-shaped ileal neobladder construction for female bladder cancer patients: oncological and functional outcomes.
Koie T, Hatakeyama S, Yoneyama T, Hashimoto Y, Kamimura N, Ohyama C
Urology 2010 Jun;75(6):1499-503. Epub 2009 Dec 6 doi: 10.1016/j.urology.2009.08.083. PMID: 19969331
A case of primary transitional cell carcinoma of the fallopian tube.
Kim JW, Cho EM, Kim YT, Han JH
J Obstet Gynaecol Res 1999 Oct;25(5):321-6. doi: 10.1111/j.1447-0756.1999.tb01170.x. PMID: 10533326

Prognosis

Phase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancer.
Chelariu-Raicu A, Levenback CF, Slomovitz BM, Wolf J, Bodurka DC, Kavanagh JJ, Morrison C, Gershenson DM, Coleman RL
Int J Gynecol Cancer 2020 Nov;30(11):1768-1774. Epub 2020 Oct 9 doi: 10.1136/ijgc-2020-001863. PMID: 33037105
Phase 1 and 2 study of carboplatin and pralatrexate in patients with recurrent, platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer.
Del Carmen MG, Supko JG, Horick NK, Rauh-Hain JA, Clark RM, Campos SM, Krasner CN, Atkinson T, Birrer MJ
Cancer 2016 Nov 15;122(21):3297-3306. Epub 2016 Jul 15 doi: 10.1002/cncr.30196. PMID: 27421044
Uterus-, fallopian tube-, ovary-, and vagina-sparing cystectomy followed by U-shaped ileal neobladder construction for female bladder cancer patients: oncological and functional outcomes.
Koie T, Hatakeyama S, Yoneyama T, Hashimoto Y, Kamimura N, Ohyama C
Urology 2010 Jun;75(6):1499-503. Epub 2009 Dec 6 doi: 10.1016/j.urology.2009.08.083. PMID: 19969331
A case of primary transitional cell carcinoma of the fallopian tube.
Kim JW, Cho EM, Kim YT, Han JH
J Obstet Gynaecol Res 1999 Oct;25(5):321-6. doi: 10.1111/j.1447-0756.1999.tb01170.x. PMID: 10533326
Transitional cell carcinoma of the endometrium and endometrial carcinoma with transitional cell differentiation.
Lininger RA, Ashfaq R, Albores-Saavedra J, Tavassoli FA
Cancer 1997 May 15;79(10):1933-43. PMID: 9149020

Clinical prediction guides

New concept in urologic surgery: The total extended genital sparing radical cystectomy in women.
Cisternino A, Capone L, Rosati A, Latiano C, Sebastio N, Colella A, Cretì G
Arch Ital Urol Androl 2023 May 22;95(2):11058. doi: 10.4081/aiua.2023.11058. PMID: 37212881
Transitional cell carcinoma of the endometrium and endometrial carcinoma with transitional cell differentiation.
Lininger RA, Ashfaq R, Albores-Saavedra J, Tavassoli FA
Cancer 1997 May 15;79(10):1933-43. PMID: 9149020

Supplemental Content

Table of contents

    Practice guidelines

    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...